Trpv1 and endocannabinoids: Emerging molecular signals that modulate mammalian vision

Cells

Volumn 3, Issue 3, 2014, Pages 914-938

  Ryskamp, Daniel A ^a   Redmon, Sarah ^a   Jo, Andrew O ^a   Križaj, David ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

CB1 receptors; Endocannabinoids; Retinal ganglion cells; TRPV1 channels

Indexed keywords

CAPSAZEPINE; ENDOCANNABINOID; VANILLOID RECEPTOR 1;

EXCITOTOXICITY; GENE DELETION; HUMAN; MAMMAL; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE EXCITABILITY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; RETINA GANGLION CELL; REVIEW; SIGNAL TRANSDUCTION; VISUAL INFORMATION;

MAMMALIA;

EID: 85056746538     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3030914     Document Type: Review

References (160)

1. Minke, B. Light-induced reduction in excitation efficiency in the trp mutant of Drosophila. J. Gen. Physiol. 1982, 79, 361–385.
2. Caterina, M.J.; Schumacher, M.A.; Tominaga, M.; Rosen, T.A.; Levine, J.D.; Julius, D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 1997, 389, 816–824.
3. Clapham, D.E. TRP channels as cellular sensors. Nature 2003, 426, 517–524.
4. Suzuki, M.; Mizuno, A.; Kodaira, K.; Imai, M. Impaired pressure sensation in mice lacking TRPV 4. J. Biol. Chem. 2003, 278, 22664–22668.
5. Watanabe, H.; Vriens, J.; Prenen, J.; Droogmans, G.; Voets, T.; Nilius, B. Anandamide and arachidonic acid use epoxyeicosatrienoic acid to activate TRPV4 channels. Nature 2003, 424, 434–438.
6. Kraft, R.; Harteneck, C. The mammalian melastatin-related transient receptor potential cation channels: An overview. Pflugers Arch. 2005, 451, 204–211.
7. Phelps, C.B.; Wang, R.R.; Choo, S.S.; Gaudet, R. Differential regulation of TRPV1, TRPV3, and TRPV4 sensitivity through a conserved binding site on the ankyrin repeat domain. J. Biol. Chem. 2010, 285, 731–740.
8. Nilius, B.; Owsianik, G. Transient receptor potential channelopathies. Pflugers Arch. 2010, 460, 437–450.
9. Kraft, R.; Grimm, C.; Grosse, K.; Hoffmann, A.; Sauerbruch, S.; Kettenmann, H.; Schultz, G.; Harteneck, C. Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. Am. J. Physiol. Cell Physiol. 2004, 286, 129–137.
10. Shen, Y.; Heimel, J.A.; Kamermans, M.; Peachey, N.S.; Gregg, R.G.; Nawy, S. A transient receptor potential-like channel mediates synaptic transmission in rod bipolar cells. J. Neurosci. 2009, 29, 6088–6093.
11. Gavva, N.R.; Bannon, A.W.; Surapaneni, S.; Hovland, D.N.; Lehto, S.G.; Gore, A.; Juan, T.; Deng, H.; Han, B.; Klionsky, L. et al. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J. Neurosci. 2007, 27, 3366–3374.
12. Sudbury, J.R.; Ciura, S.; Sharif-Naeini, R.; Bourque, C.W. Osmotic and thermal control of magnocellular neurosecretory neurons-role of an N-terminal variant of TRPV 1. Eur. J. Neurosci. 2010, 32, 2022–2030.
13. Dunn, K.M.; Hill-Eubanks, D.C.; Liedtke, W.B.; Nelson, M.T. TRPV4 channels stimulate Ca2+-induced Ca2+ release in astrocytic endfeet and amplify neurovascular coupling responses. Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 6157–6162.
14. Filosa, J.A.; Yao, X.; Rath, G. TRPV4 and the regulation of vascular tone. J. Cardiovasc. Pharmacol. 2013, 61, 113–119.
15. Caterina, M.J.; Leffler, A.; Malmberg, A.B.; Martin, W.J.; Trafton, J.; Petersen-Zeitz, K.R.; Koltzenburg, M.; Basbaum, A.I.; Julius, D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Sci. 2000, 288, 306–313.
16. Ward, N.J.; Ho, K.W.; Lambert, W.S.; Weitlauf, C.; Calkins, D.J. Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection. J. Neurosci. 2014, 34, 3161–3170.
17. Ryskamp, D.A.; Witkovsky, P.; Barabas, P.; Huang, W.; Koehler, C.; Akimov, N.P.; Lee, S.H.; Chauhan, S.; Xing, W.; Renteria, R.C. et al. The polymodal ion channel transient receptor potential vanilloid 4 modulates calcium flux, spiking rate, and apoptosis of mouse retinal ganglion cells. J. Neurosci. 2011, 31, 7089–7101.
18. Gilliam, J.C.; Wensel, T.G. TRP channel gene expression in the mouse retina. Vis. Res. 2011, 51, 2440–2452.
19. Molnar, T.; Barabas, P.; Birnbaumer, L.; Punzo, C.; Kefalov, V.; Križaj, D. Store-operated channels regulate intracellular calcium in mammalian rods. J. Physiol. 2012, 590, 3465–3481.
20. Tóth, A.; Czikora, Á.; Pásztor, E.T.; Dienes, B.; Bai, P.; Csernoch, L.; Rutkai, I.; Csató, V.; Mányiné, I.S.; Pórszász, R. et al. Vanilloid receptor-1 (TRPV1) expression and function in the vasculature of the rat. J. Histochem. Cytochem. 2014, 62, 129–144.
21. Sekaran, S.; Lall, G.S.; Ralphs, K.L.; Wolstenholme, A.J.; Lucas, R.J.; Foster, R.G.; Hankins, M.W. 2-Aminoethoxydiphenylborane is an acute inhibitor of directly photosensitive retinal ganglion cell activity in vitro and in vivo. J. Neurosci. 2007, 27, 3981–3986.
22. Xue, T.; Do, M.T.H.; Riccio, A.; Jiang, Z.; Hsieh, J.; Wang, H.C.; Merbs, S.L.; Welsbie, D.S.; Yoshioka, T.; Weissgerber, P. et al. Melanopsin signaling in mammalian iris and retina. Nature 2011, 479, 67–73.
23. Albert, E.S.; Bec, J.M.; Desmadryl, G.; Chekroud, K.; Travo, C.; Gaboyard, S.; Bardin, F.; Marc, I.; Dumas, M.; Lenaers, G. et al. TRPV4 channels mediate the infared laser-evoked response in sensory neurons. J. Neurophysiol. 2012, 107, 3227–3234.
24. Montell, C.; Jones, K.; Hafen, E.; Rubin, G. Rescue of the Drosophila phototransduction mutation trp by germline transformation. Science 1985, 230, 1040–1043.
25. Morgans, C.W.; Zhang, J.; Jeffrey, B.G.; Nelson, S.M.; Burke, N.S.; Duvoisin, R.M.; Brown, R.L. TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 19174–19178.
26. Krol, J.; Busskamp, V.; Markiewicz, I.; Stadler, M.B.; Ribi, S.; Richter, J.; Duebel, J.; Bicker, S.; Fehling, H.J.; Schübeler, D. et al. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 2010, 141, 618–631
27. Moiseenkova-Bell, V.Y.; Stanciu, L.A.; Serysheva, I.I.; Tobe, B.J.; Wensel, T.G. Structure of TRPV1 channel revealed by electron cryomicroscopy. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 7451–7455.
28. Arniges, M.; Fernández-Fernández, J.M.; Albrecht, N.; Schaefer, M.; Valverde, M.A. Human TRPV4 channel splice variants revealed a key role of ankyrin domains in multimerization and trafficking. J. Biol. Chem. 2006, 281, 1580–1586.
29. Lishko, P.V.; Procko, E.; Jin, X.; Phelps, C.B.; Gaudet, R. The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. Neuron 2007, 54, 905–918.
30. Everaerts, W.; Nilius, B.; Owsianik, G. The vanilloid transient receptor potential channel TRPV4: From structure to disease. Prog. Biophys. Mol. Biol. 2010, 103, 2–17.
31. Tominaga, M.; Caterina, M.J.; Malmberg, A.B.; Rosen, T.A.; Gilbert, H.; Skinner, K.; Raumann, B.E.; Basbaum, A.I.; Julius, D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21, 531–543.
32. Numazaki, M.; Tominaga, T.; Takeuchi, K.; Murayama, N.; Toyooka, H.; Tominaga, M. Structural determinant of TRPV1 desensitization interacts with calmodulin. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 8002–8006.
33. Wu, Z.Z.; Chen, S.R.; Pan, H.L. Transient receptor potential vanilloid type 1 activation down-regulates voltage-gated calcium channels through calcium-dependent calcineurin in sensory neurons. J. Biol. Chem. 2005, 280, 18142–18151.
34. Hellwig, N.; Albrecht, N.; Harteneck, C.; Schultz, G.; Schaefer, M. Homo- and heteromeric assembly of TRPV channel subunits. J. Cell Sci. 2005, 118, 917–928.
35. Prescott, E.D.; Julius, D. A modular PIP2 binding site as a determinant of capsaicin receptor. Science 2003, 300, 1284–1288.
36. Van der Stelt, M.; Di Marzo, V. Endovanilloids. Eur. J. Biochem. 2004, 271, 1827–1834.
37. Woo, D.H.; Jung, S.J.; Zhu, M.H.; Park, C.K.; Kim, Y.H.; Oh, S.B.; Lee, C.J. Direct activation of transient receptor potential vanilloid 1 (TRPV1) by diacylglycerol (DAG). Mol. Pain 2008, 4, 1744–8069.
38. Zhang, X.; Huang, J.; McNaughton, P.A. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. Neuromol. Med. 2005, 24, 4211–4223.
39. Sanz-Salvador, L.; Andrés-Borderia, A.; Ferrer-Montiel, A.; Planells-Cases, R. Agonist- and Ca2+-dependent desensitization of TRPV1 channel targets the receptor to lysosomes for degradation. J. Biol. Chem. 2012, 287, 19462–19471.
40. Christoph, T.; Grünweller, A.; Mika, J.; Schäfer, M.K.; Wade, E.J.; Weihe, E.; Erdmann, V.A.; Frank, R.; Gillen, C.; Kurreck, J. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo. Biochem. Biophys. Res. Commun. 2006, 350, 238–243.
41. McNamara, F.N.; Randall, A.; Gunthorpe, M.J. Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). Br. J. Pharmacol. 2005, 144, 781–790.
42. Prager-Khoutorsky, M.; Khoutorsky, A.; Bourque, C.W. Unique Interweaved Microtubule Scaffold Mediates Osmosensory Transduction via Physical Interaction with TRPV 1. Neuron 2014, 83, 866–878.
43. Immke, D.C.; Gavva, N.R. The TRPV1 receptor and nociception. Semin. Cell Dev. Biol. 2006, 17, 582–591.
44. Vigna, S.R.; Shahid, R.A.; Nathan, J.D.; McVey, D.C.; Liddle, R.A. Leukotriene B4 mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats. Pancreas 2011, 40, 708–714.
45. Bhave, G.; Hu, H.J.; Glauner, K.S.; Zhu, W.; Wang, H.; Brasier, D.J.; Oxford, G.S.; Gereau, R.W. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 12480–12485.
46. Mandadi, S.; Tominaga, T.; Numazaki, M.; Murayama, N.; Saito, N.; Armati, P.J.; Roufogalis, B.D.; Tominaga, M. Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCε-mediated phosphorylation at S 800. Pain 2006, 123, 106–116.
47. Tominaga, M.; Wada, M.; Masu, M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 6951–6956.
48. Puntambekar, P.; Van Buren, J.; Raisinghani, M.; Premkumar, L.S.; Ramkumar, V. Direct interaction of adenosine with the TRPV1 channel protein. J. Neurosci. 2004, 29, 153–158.
49. Nagy, I.; Sántha, P.; Jancsó, G.; Urbán, L. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur. J. Pharmacol. 2004, 500, 351–369.
50. Sanchez, J.F.; Krause, J.E.; Cortright, D.N. The distribution and regulation of vanilloid receptor VR1 and VR1 5' splice variant RNA expression in rat. Neurosci. 2001, 107, 373–381.
51. Cavanaugh, D.J.; Chesler, A.T.; Jackson, A.C.; Sigal, Y.M.; Yamanaka, H.; Grant, R.; O'Donnell, D.; Nicoll, R.A.; Shah, N.M.; Julius, D. et al. TRPV1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J. Neurosci. 2011, 31, 5067–5077.
52. Han, L.; Ma, C.; Liu, Q.; Weng, H.-J.; Cui, Y.; Tang, Z.; Kim, Y.; Nie, H.; Qu, L.; Patel, K.N. et al. A subpopulation of nociceptors specifically linked to itch. Nat. Neurosci. 2013, 16, 174–182.
53. Di Marzo, V. Targeting the endocannabinoid system: To enhance or reduce? Nat. Rev. 2008, 7, 438–455.
54. Kauer, J.A.; Gibson, H.E. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV 1. Trends in Neurosci. 2009, 32, 215–224.
55. Martins, D.; Tavares, I.; Morgado, C. "Hotheaded": The role of TRPV1 in brain functions. Neuropharmacol. 2014, 85, 151–157.
56. Marsch, R.; Foeller, E.; Rammes, G.; Bunck, M.; Kössl, M.; Holsboer, F.; Zieglgänsberger, W.; Landgraf, R.; Lutz, B.; Wotjak, C.T. Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J. Neurosci. 2007, 27, 832–839.
57. Gibson, H.E.; Edwards, J.G.; Page, R.S.; Van Hook, M.J.; Kauer, J.A. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 2008, 57, 746–759.
58. Adamczyk, P.; Miszkiel, J.; McCreary, A.C.; Filip, M.; Papp, M.; Przegaliński, E. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats. Brain Res. 2012, 1444, 45–54.
59. Osaka, T.; Kobayashi, A.; Lee, T.H.; Namba, Y.; Inoue, S.; Kimura, S. Lack of integrative control of heat production and heat loss after capsaicin administration. Pflugers Arch. 2000, 440, 440–445.
60. Dawbarn, D.; Harmar, A.J.; Pycock, C.J. Intranigral injection of capsaicin enhances motor activity and depletes nigral 5-hydroxytrptamine but not substance P. Neuropharmacol. 1981, 20, 341–346.
61. Szallasi, A.; Nilsson, S.; Farkas-Szallasi, T.; Blumberg, P.M.; Hökfelt, T.; Lundberg, J.M. Vanilloid (capsaicin) receptors in the rat: Distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res. 1995, 703, 175–183.
62. Benninger, F.; Freund, T.F.; Hájos, N. Control of excitatory synaptic transmission by capsaicin is unaltered in TRPV1 vanilloid receptor knockout mice. Neurochem. Int. 2008, 52, 89–94.
63. Everaerts, W.; Sepúlveda, M.R.; Gevaert, T.; Roskams, T.; Nilius, B.; De Ridder, D. Where is TRPV1 expressed in the bladder, do we see the real channel? Naunyn Schmiedebergs Arch Pharmacol. 2009, 379, 421–425.
64. Brown, T.E.; Chirila, A.M.; Schrank, B.R.; Kauer, J.A. Loss of interneuron LTD and attenuated pyramidal cell LTP in TRPV1 and TRPV3 KO mice. Hippocampus 2013, 23, 662–671.
65. Ritter, S.; Dinh, T.T. Capsaicin-induced neuronal degeneration: Silver impregnation of cell bodies, axons, and terminals in the central nervous system of the adult rat. J. Comp. Neurol. 1988, 271, 79–90.
66. Ritter, S.; Dinh, T. Capsaicin-induced neuronal degeneration in the brain and retina of preweanling rats. J. Comp. Neurol. 1990, 296, 447–461.
67. Marc, R.E.; Jones, B.W.; Watt, C.B.; Anderson, J.R.; Sigulinsky, C.; Lauritzen, S. Retinal connectomics: Towards complete, accurate networks. Prog. Retin. Eye Res. 2013, 37, 141–162.
68. Bringmann, A.; Iandiev, I.; Pannicke, T.; Wurm, A.; Hollborn, M.; Wiedemann, P.; Osborne, N.N.; Reichenbach, A. Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects. Prog. Retin. Eye Res. 2009, 28,423–451.
69. Cuenca, N.; Fernández-Sánchez, L.; Campello, L.; Maneu, V.; De la Villa, P.; Lax, P.; Pinilla, I. Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog. Retin. Eye Res. 2014, in press.
70. Chalupa, L.M.; Werner, J.S. The Visual Neurosciences; MIT Press: Cambridge, MA, USA, 2003.
71. Sappington, R.M.; Calkins, D.J. Contribution of TRPV1 to microglia-derived IL-6 and NFκB translocation with elevated hydrostatic pressure. Investig. Ophthalmol. Vis. Sci. 2008, 49, 3004–3017.
72. Sappington, R.M.; Sidorova, T.; Long, D.J.; Calkins, D.J. TRPV1: Contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure. Investig. Ophthalmol. Vis. Sci. 2009, 50, 717–728.
73. Križaj, D.; Ryskamp, D.A.; Tian, N.; Tezel, G.; Mitchell, C.H.; Slepak, V.Z.; Shestopalov, V.I. From mechanosensitivity to inflammatory responses: New players in the pathology of glaucoma. Curr. Eye Res. 2014, 39, 105–119.
74. Szikra, T.; Cusato, K.; Thoreson, W.B.; Barabas, P.; Bartoletti, T.M.; Križaj, D. Depletion of calcium stores regulates calcium influx and signal transmission in rod photoreceptors. J. Physiol. 2008, 586, 4859–4875.
75. Beckel, J.M.; Argall, A.J.; Lim, J.C.; Xia, J.; Lu, W.; Coffey, E.E.; Macarak, E.J.; Shahidullah, M.; Delamere, N.A.; Zode, G.S. et al. Mechanosensitive release of adenosine 5'-triphosphate through pannexin channels and mechanosensitive upregulation of pannexin channels in optic nerve head astrocytes: A mechanism for purinergic involvement in chronic strain. Glia 2014, 62, 1486–1501
76. Ritter, S.; Dinh, T. Age-related changes in capsaicin-induced degeneration in rat brain. J. Comp. Neurol. 1992, 318, 103–116.
77. Ritter, S.; Dinh, T.T. Prior optic nerve transection reduces capsaicin-induced degeneration in rat subcortical visual structures. J. Comp. Neurol. 1991, 308, 79–90.
78. Jancsó, G.; Király, E.; Jancsó-Gábor, A. Direct evidence for an axonal site of action of capsaicin. Naunyn Schmiedebergs Arch. Pharmacol. 1980, 313, 91–94.
79. Kim, C.S.; Kawada, T.; Kim, B.S.; Han, I.S.; Choe, S.Y.; Kurata, T.; Yu, R. Capsaicin exhibits anti-inflammatory property by inhibiting IκB-a degradation in LPS-stimulated peritoneal macrophages. Cell Signal. 2003, 15, 299–306.
80. Costa, R.M.; Liu, L.; Nicolelis, M.A.L.; Simon, S.A. Gustatory effects of capsaicin that are independent of TRPV1 receptors. Chem. Senses 2005, 30, i198–i200.
81. Athanasiou, A.; Smith, P.A.; Vakilpour, S.; Kumaran, N.M.; Turner, A.E.; Bagiokou, D.; Layfield, R.; Ray, D.E.; Westwell, A.D.; Alexander, S.P. et al. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: How vanilloids cause non-vanilloid receptor mediated cell death. Biochem. Biophys. Res. Commun. 2007, 354, 50–55.
82. Di Marzo, V.; De Petrocellis, L.; Fezza, F.; Ligresti, A.; Bisogno, T. Anandamide receptors. Prostaglandins Leukot. Essent. Fat. Acids 2002, 66, 377–391.
83. Xu, Y.; Dhingra, A.; Fina, M.E.; Koike, C.; Furukawa, T.; Vardi, N. mGluR6 deletion renders the TRPM1 channel in retina inactive. J. Neurophysiol. 2012, 107, 948–957.
84. Docherty, R.J.; Yeat, J.C.; Piper, A.S. Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture. Br. J. Pharmacol. 1997, 121, 1461–1467.
85. Liu, L.; Simon, S.A. Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia. Neurosci. Lett. 1997, 228, 29–32.
86. Ray, A.M.; Benham, C.D.; Roberts, J.C.; Gill, C.H.; Lanneau, C.; Gitterman, D.P.; Harries, M.; Davis, J.B.; Davies, C.H. Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibition I(h). J. Neurosci. 2003, 23, 10146–10153.
87. Yamamura, H.; Ugawa, S.; Ueda, T.; Nagao, M.; Shimada, S. Capsazepine is a novel activator of the δ subunit of the human epithelial Na+ channel. J. Biol. Chem. 2004, 279, 44483–44489.
88. Nucci, C.; Gasperi, V.; Tartaglione, R.; Cerulli, A.; Terrinoni, A.; Bari, M.; De Simone, C.; Agrò, A.F.; Morrone, L.A.; Corasaniti, M.T. et al. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Investig. Ophthalmol. Vis. Sci. 2007, 48, 2997–3004.
89. Martinez-Garcia, M.C.; Martinez, T.; Pañeda, C.; Gallego, P.; Jimenez, A.I.; Merayo, J. Differential expression and localization of transient receptor potential vanilloid 1 in rabbit and human eyes. Histol. Histopathol. 2013, 28, 1507–1516.
90. Zimov, S.; Yazulla, S. Localization of vanilloid receptor 1 (TRPV1/VR1)-like immunoreactivity in goldfish and zebrafish retinas: Restriction to photoreceptor synaptic ribbons. J. Neurocytol. 2004, 33, 441–452.
91. Zimov, S.; Yazulla, S. Vanilloid receptor 1 (TRPV1/VR1) co-localizes with fatty acid amide hydrolase (FAAH) in retinal amacrine cells. Vis. Neurosci. 2007, 24, 581–591.
92. Leonelli, M.; Martins, D.O.; Kihara, A.H.; Britto, L.R. Ontogenetic expression of the vanilloid receptors TRPV1 and TRPV2 in the rat retina. Int. J. Dev. Neurosci. 2009, 27, 709–718.
93. Leonelli, M.; Martins, D.O.; Britto, L.R. TRPV1 receptors modulate retinal development. Int. J. Dev. Neurosci. 2011, 29, 405–413.
94. Leonelli, M.; Martins, D.O.; Britto, L.R. TRPV1 receptors are involved in protein nitration and Müller cell reaction in the acutely axotomized rat retina. Exp. Eye Res. 2010, 91, 755–768.
95. Maione, S.; Cristino, L.; Migliozzi, A.L.; Georgiou, A.L.; Starowicz, K.; Salt, T.E.; Di Marzo, V. TRPV1 channels control synaptic plasticity in the developing superior colliculus. J. Physiol. 2009, 587, 2521–2535.
96. Fan, S.F.; Yazulla, S. Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2. Vis. Neurosci. 2003, 20, 177–188.
97. Warrier, A.; Wilson, M. Endocannabinoid signaling regulates spontaneous transmitter release from embryonic retinal amacrine cells. Vis. Neurosci. 2007, 24, 25–35.
98. Yazulla, S. Endocannabinoids in the retina: From marijuana to neuroprotection. Prog. Retin. Eye Res. 2008, 27, 501–526.
99. Straiker, A.; Stella, N.; Piomelli, D.; Mackie, K.; Karten, H.J.; Maguire, G. Cannabinoid CB1 receptors and ligands in vertebrate retina: Localization and function of an endogenous signaling system. Proc. natl. Acad. Sci. U.S.A. 1999, 96, 14565–14570.
100. Glaser, S.T.; Deutsch, D.G.; Studholme, K.M.; Zimov, S.; Yazulla, S. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. Vis. Neurosci. 2005, 22, 693–705.
101. Ho, K.W.; Lambert, W.S.; Calkins, D.J. Activation of TRPV1 cation channel contributes to stress-induced astrocyte migration. Glia 2014, Epub ahead of print.
102. Jo, A.O.; Ryskamp, D.A.; Redmon, S.; Barabas, P.; Križaj, D. Nonretrograde endocannabinoid signaling modulates retinal ganglion cell calcium homeostasis through the TRPV1cation channel. Investig. Ophtalmol. Vis. Sci. 2014, 55, E-Abstract 3021.
103. Szikra, T.; Barabas, P.; Bartoletti, T.M.; Huang, W.; Akopian, A.; Thoreson, W.B.; Križaj, D. Calcium homeostasis and cone signaling are regulated by interactions between calcium stores and plasma membrane ion channels. PLoS One 2009, 4, e6723.
104. Ahluwalia, J.; Urban, L.; Bevan, S.; Nagy, I. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur. J. Neurosci. 2003, 12, 2611–2618.
105. Kishimoto, Y.; Kano, M. Endogenous cannabinoid signaling through the CB1 receptor is essential for cerebellum-dependent discrete motor learning. J. Neurosci. 2006, 26, 8829–8837.
106. Cadas, H.; Gaillet, S.; Beltramo, M.; Venance, L.; Piomelli, D. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neurosci. 1996, 16, 3934–3942.
107. De Petrocellis, L.; Schiano, M.A.; Imperatore, R.; Cristino, L.; Starowicz, K.; Di Marzo, V. A re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: Enantioselectivity and effects at other TRP channels and in sensory neurons. Br. J. Pharmacol. 2012, 167, 1643–1651.
108. Tóth, B.I.; Dobrosi, N.; Dajnoki, A.; Czifra, G.; Oláh, A.; Szöllosi, A.G.; Juhász, I.; Sugawara, K.; Paus, R.; Bíró, T. Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J. Invest. Dermatol. 2011, 131, 1095–1104
109. Jeske, N.A.; Patwardhan, A.M.; Gamper, N.; Price, T.J.; Akopian, A.N.; Hargreaves, K.M. Cannabinoid WIN 55,212–2 regulates TRPV1 phosphorylation in sensory neurons. J. Biol. Chem. 2006, 281, 32789–32890.
110. Buckley, N.E.; Hansson, S.; Harta, G.; Mezey, E. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 1998, 82, 1131–1149.
111. Porcella, A.; Maxia, C.; Gessa, G.L.; Pani, L. The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. Eur. J. Neurosci. 2000, 12, 1123–1127.
112. Hu, S.S.J.; Arnold, A.; Hutchens, J.M.; Radicke, J.; Cravatt, B.F.; Wager-Miller, J.; Mackie, K.; Straiker, A. Architecture of cannabinoid signaling in mouse retina. J. Comp. Neurol. 2010, 518, 3848–3866.
113. Wilkinson-Berka, J.L.; Alousis, N.S.; Kelly, D.J.; Gilbert, R.E. COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2003, 44, 974–979.
114. Struik, M.L.; Yazulla, S.; Kamermans, M. Cannabinoid agonist WIN 55212-2 speeds up the cone response to light offset in goldfish retina. Vis. Neurosci. 2006, 23, 285–293.
115. Matias, I.; Wang, J.W.; Moriello, A.S.; Nieves, A.; Woodward, D.F.; Di Marzo, V. Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. Prostaglandins Leukot. Essent. Fat. Acids 2006, 75, 413–418.
116. Kumar, R.N.; Chambers, W.A.; Pertwee, R.G. Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia 2001, 56, 1059–1068.
117. Hwang, S.W.; Cho, H.; Kwak, J.; Lee, S.Y.; Kang, C.J.; Jung, J.; Cho, S.; Min, K.H.; Suh, Y.G.; Kim, D. et al. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 6155–6160.
118. Piomelli, D. The ligand that came from within. Trends in Pharmacol. Sci. 2001, 22, 17–19.
119. Russo, E.B.; Merzouki, A.; Mesa, J.M.; Frey, K.A.; Bach, P.J. Cannabis improves night vision: A case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco. J. Ethnopharmacol. 2004, 93, 99–104.
120. Adams, A.J.; Brown, B.; Haegerstrom-Portnoy, G.; Flom, M.C.; Jones, R.T. Evidence for acute effects of alcohol and marijuana on color discrimination. Percept. Psychophys. 1976, 20, 119–124.
121. Dawson, W.W.; Jimenez-Antillon, C.F.; Perez, J.M.; Zeskind, J.A. Marijuana and vision—after ten years’ use in Costa Rica. Investig. Ophtalmol. Vis. Sci. 1977, 16, 689–699.
122. Straiker, A.; Sullivan, J.M. Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander. J. Neurophysiol. 2003, 89, 2647–2654.
123. Lalonde, M.R.; Jollimore, C.A.B.; Stevens, K.; Barnes, S.; Kelly, M.E.M. Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells. Mol. Vis. 2006, 12, 1160–1166.
124. Middleton, T.P.; Protti, D.A. Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cells. Vis. Neurosci. 2011, 28, 393–402.
125. El-Remessy, A.B.; Khalil, I.E.; Matragoon, S.; Abou-Mohamed, G.; Tsai, N.J.; Roon, P.; Caldwell, R.B.; Caldwell, R.W.; Green, K.; Liou, G.I. Neuroprotective effect of (-)Δ9-tetrahydrocannabinol and cannabidiol in N-Methyl-D-Aspartate-induced retinal neurotoxicity. Am. J. Pathol. 2003, 163, 1997–2008.
126. Opere, C.A.; Zheng, W.D.; Zhao, M.; Lee, J.S.; Kulkarni, K.H.; Ohia, S.E. Inhibition of potassium- and ischemia-evoked [3H] D-aspartate release from isolated bovine retina by cannabinoids. Curr. Eye Res. 2006, 31, 645–653.
127. Lax, P.; Esquiva, G.; Altavilla, C.; Cuenca, N. Neuroprotective effect of the cannabinoid agonist HU210 on retinal degeneration. Exp. Eye Res. 2014, 120, 175–185.
128. Chen, J.; Matias, I.; Dinh, T.; Lu, T.; Venezia, S.; Nieves, A.; Woodward, D.F.; Di Marzo, V. Finding of endocannabinoids in human eye tissues: Implications for glaucoma. Biochem. Biophys. Res. Commun. 2005, 330, 1062–1067.
129. Slusar, J.E.; Cairns, E.A.; Szczesniak, A.M.; Bradshaw, H.B.; Di Polo, A.; Kelly, M.E. The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy. Neuropharmacology 2013, 72, 116–125.
130. Millns, P.J.; Chimenti, M.; Ali, N.; Ryland, E.; de Lago, E.; Fernandez-Ruiz, J.; Chapman, V.; Kendall, D.A. Effects of inhibition of fatty acid amide hydrolase vs the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors. Eur. J. Neurosci. 2006, 24, 3489–3495.
131. Shin, C.Y.; Shin, J.; Kim, B.M.; Wang, M.H.; Jang, J.H.; Surh, Y.J.; Oh, U. Essential role of mitochondrial permeability transition in vanilloid receptor 1-dependent cell death of sensory neurons. Mol. Cell Neurosci. 2003, 24, 57–68.
132. Kim, S.R.; Lee, D.Y.; Chung, E.S.; Oh, U.; Kim, S.U.; Jin, B.K. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. J. Neurosci. 2005, 25, 662–671.
133. Kim, S.R.; Kim, S.U.; Oh, U.; Jin, B.K. Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca2+-mediated mitochondrial damage and cytochrome c release. J. Immunol. 2006, 177, 4322–4329.
134. Shirakawa, H.; Yamaoka, T.; Sanpei, K.; Sasaoka, H.; Nakagawa, T.; Kaneko, S. TRPV1 stimulation triggers apoptotic cell death of rat cortical neurons. Biochem. Biophys. Res. Commun. 2008, 377, 1211–1215.
135. Birder, L.A.; Nakamura, N.Y.; Kiss, S.; Nealen, M.L.; Barrick, S.; Kanai, A.J.; Wang, E.; Ruiz, G.; de Groat, W.C.; Apodaca, G. et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV 1. Nat. Neurosci. 2002, 5, 856–860.
136. Eijkelkamp, N.; Quick, K.; Wood, J.N. Transient receptor potential channels and mechanosensation. Neurosci. 2013, 36, 519–546.
137. Ho, K.W.; Ward, N.J.; Calkins, D.J. TRPV1: A stress response protein in the central nervous system. Am. J. Neurodegener. Dis. 2012, 1, 1–14.
138. Sanderson, J.; Rhodes, J.; Osborne, A.; Broadway, D. Increased hydrostatic pressure does not cause loss of retinal ganglion cell viability in human organotypic retinal cultures. Acta Ophthalmol. 2011, 89, doi:10.1111/j.1755–3768.2011.1255.x.
139. Burgoyne, C.F. A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp. Eye Res. 2011, 93, 120–132.
140. Veldhuis, W.B.; van der Stelt, M.; Wadman, M.W.; van Zadelhoff, G.; Maccarrone, M.; Fezza, F.; Veldink, G.A.; Vliegenthart, J.F.G.; Bär, P.R.; Nicolay, K. et al. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: Role of vanilloid receptors and lipoxygenases. J. Neurosci. 2003, 23, 4127–4133.
141. Sappington, R.M.; Chan, M.; Calkins, D.J. Interleukin-6 protects retinal ganglion cells from pressure-induced death. Investig. Ophthalmol. Vis. Sci. 2006, 47, 2932–2942.
142. Sakamoto, K.; Kuroki, T.; Okuno, Y.; Sekiya, H.; Watanabe, A.; Sagawa, T.; Ito, H.; Mizuta, A.; Mori, A.; Nakahara, T. et al. Activation of the TRPV1 channel attenuates N-methyl-D-aspartic acid-induced neuronal injury in the rat retina. Eur. J. Pharmacol. 2014, 733, 13–22.
143. Bronzetti, E.; Artico, M.; Koyacs, I.; Felici, L.M.; Magliulo, G.; Vignone, D.; D'Ambrosio, A.; Forte, F.; De Liddo, R.; Feher, J. Expression of neurotransmitters and neurotrophins in neurogenic inflammation of the rat retina. Eur. J. Histochem. 2007, 51, 251–260.
144. Yang, J.H.; Guo, Z.; Zhang, T.; Meng, X.X.; Sun, T.; Wu, J. STZ treatment induced apoptosis of retinal cells and effect of up-regulation of calcitonin gene related peptide in rats. J. Diabetes Complicat. 2013, 27, 531–537.
145. Ching, L.C.; Kou, Y.R.; Shyue, S.K.; Su, K.H.; Wei, J.; Cheng, L.C.; Yu, Y.B.; Pan, C.C.; Lee, T.S. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1. Cardiovasc. Res. 2011, 91, 492–501.
146. Martin, E.; Dahan, D.; Cardouat, G.; Gillibert-Duplantier, J.; Marthan, R.; Savineau, J.P.; Ducret, T. Involvement of TRPV1 and TRPV4 channels in migration of rat pulmonary arterial smooth muscle cells. Pflugers Arch. 2012, 464, 261–272.
147. Donnerer, J.; Lembeck, F. Analysis of the effects of intravenously injected capsaicin in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 1982, 320, 54–57.
148. Wang, L.; Wang, D.H. TRPV1 gene knockout impairs post ischemic recovery in isolated perfused heart in mice. Circ. 2005, 112, 3617–3623.
149. Kark, T.; Bagi, Z.; Lizanecz, E.; Pásztor, E.T.; Erdei, N.; Czikora, A.; Papp, Z.; Edes, I.; Pórszász, R.; Tóth, A. Tissue-specific regulation of microvascular diameter: Opposite functional roles of neuronal and smooth muscle located vanilloid receptor-1. Mol. Pharmacol. 2008, 73, 1405–1412.
150. Guarini, G.; Ohanyan, V.A.; Kmetz, J.G.; DelloStritto, D.J.; Thoppil, R.J.; Thodeti, C.K.; Meszaros, J.G.; Damron, D.S.; Bratz, I.N. Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: Role of nitric oxide and BK channels. Am. J. Physiol. Heart Circ. Physiol. 2012, 303, H216-H223.
151. Leonelli, M.; Martins, D.O.; Britto, L.R. Retinal cell death induced by TRPV1 activation involves NMDA signaling and upregulation of nitric oxide synthases. Cell Mol. Neurobiol. 2013, 33, 379–392.
152. Prieto, D.; Benedito, S.; Nielsen, P.J.; Nyborg, N.C.B. Calcitonin gene-related peptide is a potent vasodilator of bovine retinal arteries in vitro. Exp. Eye Res. 1991, 53, 399–405.
153. Samudre, S.S.; Nicholls, M.; Williams, P.B.; Lattanzio, F.A. Endocannabinoid analogs reduce human retinal vascular endothelial cell proliferation. FASEB J. 2009, 23, E-Abstract LB404.
154. Turner, H.; Fleig, A.; Stokes, A.; Kinet, J.P.; Penner, R. Discrimination of intracellular calcium store subcompartments using TRPV1 (transient receptor potential channel, vanilloid subfamily member 1) release channel activity. Biochem. J. 2003, 371, 341–350.
155. Križaj, D.; Bao, J.X.; Schmitz, Y.; Witkovsky, P.; Copenhagen, D.R. Caffeine-sensitive calcium stores regulate synaptic transmission from retinal rod photoreceptors. J. Neurosci. 1999, 19, 7249–7261.
156. Chen, M.; Križaj, D.; Thoreson, W.B. Intracellular calcium stores drive slow non-ribbon vesicle release from rod photoreceptors. Front. Cell. Neurosci. 2014, 8, doi:10.3389/fncel.2014.00020.
157. Križaj, D.; Copenhagen, D.R. Calcium regulation in photoreceptors. Front. Biosci. 2002, 7, d2023–d2044.
158. Fain, G.L.; Granda, A.M.; Maxwell, J.M. Voltage signal of photoreceptors at visual threshold. Nature 1977, 265, 181–183.
159. Thoreson, W.B.; Rabi, K.; Townes-Anderson, E.; Heidelberger, R. A highly Ca2+-sensitive pool of vesicles contributes to linearity at the rod photoreceptor ribbon synapse. Neuron 2004, 42, 595–605.
160. Ciura, S.; Liedtke, W.; Bourque, C.W. Hypertonicity sensing in organum vasculosum lamina terminalis neurons: A mechanical process involving TRPV1 but not TRPV 4. J. Neurosci. 2011, 31, 14669–14676.